Hims & Hers Health, Inc. (HIMS)
Pre-market:
| Previous close | 12.15 |
| Open | 12.27 |
| Bid | 12.92 x 900 |
| Ask | 12.99 x 800 |
| Day's range | 12.22 - 13.01 |
| 52-week range | 5.65 - 17.16 |
| Volume | |
| Avg. volume | 6,344,574 |
| Market cap | 2.775B |
| Beta (5Y monthly) | 0.96 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Hims & Hers Health, Inc. Reports First Quarter 2024 Financial Results
SAN FRANCISCO, May 06, 2024--Hims & Hers Health, Inc. ("Hims & Hers" or the "Company", NYSE: HIMS), the leading health and wellness platform, today announced financial results for the first quarter ended March 31, 2024 in a shareholder letter that is posted at investors.hims.com.
- Business Wire
Hims & Hers to Announce First Quarter 2024 Financial Results on May 6, 2024
SAN FRANCISCO, April 15, 2024--Hims & Hers Health, Inc. ("Hims & Hers," NYSE: HIMS), the leading health and wellness platform, today announced that it will report first quarter 2024 financial results after the market closes on Monday, May 6, 2024. The company will host a live conference call to discuss the results at 5:00 p.m. ET the same day.
- Business Wire
Hims & Hers Appoints Christopher Payne, Seasoned Tech Industry Executive, as Newest Board Member
SAN FRANCISCO, April 04, 2024--Hims & Hers Health, Inc. ("Hims & Hers", NYSE: HIMS), the leading health and wellness platform, today announced the appointment of Christopher Payne to the company’s Board of Directors.
